Duisburg, November 12, 2026. In the third quarter of 2026, the Duisburg-based PCC Group continued the positive business development of the first six months. Earnings before interest, taxes, depreciation and amortization (EBITDA) rose significantly year-on-year, by 25.1% to €30.7 million. In the first nine months, EBITDA cumulatively amounted to €75.7 million, an increase of 30.7%.
Group revenue rose by 7.3% year-on-year to €241.0 million in the third quarter. In the first nine months, it was €706.8 million, down 0.3% year-on-year, as the upward trend did not take full effect until the second quarter.
Operating income (earnings before interest and taxes, EBIT), the PCC Group generated a profit of €6.5 million in the third quarter, an increase of 67.6% compared to the same quarter of the previous year. In the first nine months, EBIT cumulatively amounted to €11.1 million (previous year: €–4.8 million).
Earnings before taxes (EBT) were slightly negative in the third quarter at –€2.6 million, but improved significantly compared with the prior-year quarter (–€9.3 million). Cumulatively, the pre-tax loss in the first nine months fell by 75.0% to –€15.8 million.
“Overall, after a rather subdued start to the 2026 financial year, the PCC Group has been recording a significant upward trend in its core activities since the beginning of March, which continued in the third quarter,” explains Riccardo Koppe, Chief Financial Officer of PCC SE, adding: “This positive business development is based on higher plant utilization and a persistently high order situation in the chemical industry in Europe and thus also in the PCC Group since the outbreak of the Iran war. As a European chemical producer, PCC guarantees customers in Europe and the USA a high level of supply stability,” explains Riccardo Koppe, “There are currently no supply bottlenecks for our own raw materials.”
Positive outlook for the year as a whole
German economy is expanding for the third quarter in a row, albeit at a low level. The Management Board of PCC SE expects this trend to continue in the fourth quarter and reaffirms its positive full-year outlook. Its 2026 guidance, published in July, forecasts revenue growth of 5% to 10% to nearly €1 billion, an increase in EBITDA before exceptional items of more than 20% to a triple-digit million-euro figure, and a return to positive EBIT.
Development in the Group segments
The segment with the highest turnover is Surfactants & Derivatives. Revenue in the third quarter rose by 9.2% year-on-year to €69.6 million, while EBITDA declined by 3.2% to €6.2 million. Since March, the segment has recorded continued high demand. Volumes and prices were above the prior-year level on average in the third quarter, but slightly below the second quarter. In the third quarter of 2026, the Polyols & Derivatives segment achieved sales of €48.0 million, a 7.3% year-on-year increase, as well as higher positive earnings at all levels. In the Chlorine & Derivatives segment, regular maintenance was carried out in the third quarter. Sales rose by 3.5% to €44.5 million in the third quarter.
The temporary standstill of silicon metal production continues. Operating cash flow in the first nine months improved from €–18.0 million in the previous year to €–3.4 million, thus exceeding our expectations. PCC continued negotiations with all parties in the third quarter to enable a sustainable economic resumption of production in the long term. The agreements are expected to be effectively implemented by the end of the year. Revenue in the Trading & Services segment rose by 41.9% to €33.4 million and EBITDA by 139.2% to €10.7 million. In the Logistics segment, intermodal container logistics defended its market leadership in Poland in the first nine months. Revenue rose by 5.3% to €42.3 million in the third quarter, while EBITDA rose by 43.0% to €8.6 million. In the Holding & Projects segment, we are currently strengthening the large PCC chemical site in Brzeg Dolny (Poland) by expanding and modernizing production facilities.
Streamlining of Group structure in the Chlorine segment completed
PCC SE is consolidating its business activities in the Chlorine & Derivatives segment. To this end, the business for the production and sale of monochloroacetic acid (MCAA), i.e. the subsidiaries MCAA SE and PCC MCAA Sp. z o.o., will be transferred to PCC Rokita SA. PCC SE and PCC Rokita SA signed the corresponding contribution agreement on October 15, 2026.
Redemption of Bullet Bonds
PCC SE repaid the ISIN DE000A3MP4P9 bond issued in 2021 at maturity on October 1, 2026. The bond bore interest at 4.00% p.a., with a repayment volume of €10.0 million.
